|
This document is a final report of an in vivo rat micronucleus assay conducted by Covance Laboratories for the Telomer Research Program Consortium, assessing the genotoxicity of a test article related to perfluorinated compounds.
|
2001 |
AR226-1198
|
zzojrxx3Oj78kEyeQ1wqrGN8B |
31 |
|
The document is a final report on a toxicity test conducted by Wildlife International, Ltd. for 3M Corporation, assessing the effects of PFOS on seedling emergence of seven plant species, completed in compliance with Good Laboratory Practice standards.
|
2001 |
AR226-1369
|
BBDwGnK9nx8n3OyBar80JxdJ |
135 |
|
This document details the analytical method validation for the determination of perfluorooctanesulfonate (PFOS) in artificial soil, conducted by Wildlife International, Ltd. for 3M Corporation, and completed on May 27, 2003, while noting compliance with Good Laboratory Practice Standards with some exceptions.
|
2001 |
AR226-1370
|
ym9zrjRZ1yaYZ26qJDGVwg9LV |
46 |
|
This document details the analytical method validation for determining perfluorooctanesulfonate (PFOS) in plant tissues, conducted by Wildlife International, Ltd. for 3M Corporation, and completed in compliance with Good Laboratory Practice Standards, although it notes an exception regarding the stability of the test substance.
|
2001 |
AR226-1371
|
rx6Bbv6y6nqJ150GN3djdKO9r |
51 |
|
DuPont expresses concerns about potentially elevated PFOA levels exceeding the 1 ppb CEG due to a new analytical technique and plans to meet with EPA Region 3 to discuss the implications and defend their findings regarding human health impacts.
|
2001 |
AR226-1680
|
p48Y3m5dXNL2dLBw6OwQ1JED |
1 |
|
This letter details allegations from a former DuPont employee regarding the company's cover-up of environmental contamination and unsafe practices related to toxic substances, including PFOA, and expresses concern for public safety and corporate misconduct.
|
2001 |
AR226-1679
|
pm9qXr3m7Dga8k3EdDgnZajmj |
3 |
|
DuPont representatives express urgent concerns to EPA Region 3 regarding the use of their CEG as a screening level for health risks associated with PFOA, while requesting a meeting to discuss their new analytical method and sampling protocol.
|
2001 |
AR226-1681
|
J3mBq9D1YBYp0pGmr8RJOGXya |
1 |
|
The document discusses the preparation of a summary on PFOA for the EPA, emphasizing that levels above DuPont's CEO limit of 1 ppb in drinking water do not constitute an emergency requiring immediate action, despite concerns about exposure from ambient air.
|
2001 |
AR226-1682
|
0qDBR5K2qxdGBnVOQ3xa4ng2k |
3 |
|
Unreadable document.
|
2001 |
AR226-1683
|
29jQZOobdGML7BeRVQy8YwMp |
1 |
|
The document discusses a communication regarding the assessment of potential off-plant impacts of PFOA, emphasizing the need to focus on chronic exposure rather than acute exposure in discussions with the West Virginia Department of Environmental Protection's Division of Air Quality.
|
2001 |
AR226-1684
|
OyyObVRBzJm2rkd67qzjZyVK |
1 |
|
The document discusses upcoming drinking water concentration tests for PFOA using a new method, indicating expected results significantly higher than previous measurements, and outlines efforts to communicate with regulators about the situation to prevent drastic actions regarding drinking water sources.
|
2001 |
AR226-1685
|
n964Z3N571bnd08YMmqXKGmRa |
1 |
|
The document discusses a meeting between DuPont and EPA Region 3 regarding PFOA, highlighting the need for recent primate study results, air monitoring data for Lubeck, and concerns about outdated analytical protocols potentially underestimating PFOA concentrations in water.
|
2001 |
AR226-1686
|
gbJKZ340zjB7rBe5y4b28kq3J |
1 |
|
The document discusses a communication between John R. Bowman and Jack S. Mandel regarding Mandel's potential involvement in PFOA-related work with DuPont, with 3M expressing no objection to his assistance as long as confidentiality is maintained.
|
2001 |
AR226-1688
|
0q0YX68mvj0YqmqXGp02Y6Vpk |
1 |
|
This document reviews the occurrence and hazards of perfluoroalkyl substances in the UK, specifically in response to 3M's decision to phase out certain fully-fluorinated alkyl products due to their severe environmental effects.
|
2001 |
AR226-1238
|
44y7y4kaQBJnKerJkqBaVY7XV |
55 |
|
The document presents a simple compartmental model developed by DuPont researchers to estimate perfluorooctanoate (PFO) blood concentrations in humans based on exposure to ammonium perfluorooctanoate (APFO) through ingestion or inhalation.
|
2001 |
AR226-1478
|
QJmkoqrkv3BRX5K97Q4XOyzyE |
10 |
|
This letter from DuPont's corporate counsel, Andrea V. Malinowski, informs the EPA that certain documents related to a lawsuit against DuPont are claimed as TSCA Confidential Business Information, while others can be made public.
|
2001 |
AR226-1245
|
5Do6aDx17b32OY47nQm2q5Mxe |
1 |
|
an acute inhalation toxicokinetic study of perfluoroctanesulfonyl fluoride (POSF) conducted by 3M, which found that while PFOS was detected in the serum of rats post-exposure, all animals tolerated the exposure without significant clinical pathology or weight loss.
|
2001 |
AR226-1729
|
Expgjk4Gx56BQ383GMEe7GNRg |
17 |
|
The document summarizes a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on mallards, detailing the experimental design, treatment levels, and observations of toxicity, which led to the termination of higher concentration groups due to adverse effects.
|
2001 |
AR226-1741
|
MGdVaYzEk8JDnNNvLQDyEyNm7 |
11 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from egg components using HPLC-Electrospray/Mass Spectrometry, which was completed in compliance with US EPA TSCA Good Laboratory Practice Standards.
|
2001 |
AR226-1740
|
X7Q7QQEpZ94nMOeD57ERzDegK |
102 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from mallard serum and liver using HPLC-Electrospray/Mass Spectrometry, ensuring compliance with EPA Good Laboratory Practice Standards.
|
2001 |
AR226-1739
|
09z6OOveopyYb84G5L92nN3k |
104 |
|
The document is a C-8 Data Summary Report submitted by DuPont for the Washington Works facility and associated landfills, detailing the results of investigations and sampling related to perfluorinated compounds, specifically C-8, to fulfill requirements of a Multi-Media Consent Order.
|
2001 |
AR226-1503
|
KR8RZg3G9O7vdvVgXLex22NEo |
304 |
|
This laboratory report details a PFOS dietary LC50 study conducted by 3M Environmental Technology & Safety Services on northern bobwhite birds, revealing significant variability in PFOS levels in sera among individual animals while liver PFOS levels were more consistent and generally increased with dose level.
|
2001 |
AR226-1748
|
gEQMV7pxgX5qo4wKVeOZGw4DG |
16 |
|
A dietary chronic definitive reproductive study on PFOS (perfluorooctanesulfonate) was conducted on northern bobwhite quail, revealing overt signs of toxicity at higher concentrations, leading to the termination of the 150 ppm and 50 ppm treatments due to adverse effects.
|
2001 |
AR226-1752
|
2JxEDMGRbppjE5Mwd2LK2deQr |
11 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from quail serum and liver using HPLC-Electrospray/Mass Spectrometry, which was performed in compliance with EPA Good Laboratory Practice Standards.
|
2001 |
AR226-1751
|
b52X5XEXqNQx5V8DV3X7LGwV3 |
102 |
|
The document reports on a study conducted by the Centre National de la Recherche Scientifique to investigate the atmospheric fate of fluorinated alcohols, specifically focusing on the kinetic rate constants of trifluoropropanol (TFP) and tridecafluoro-octanol (TDO) with hydroxyl radicals, as surrogates for 2-perfluoro-n-octyl ethanol (2
|
2001 |
AR226-1520
|
y8Kq1wBM42ywkGVe5Y2ZKe4d |
3 |
|
The document is a final report of a reproduction study on PFOS conducted on the Northern Bobwhite by Wildlife International, Ltd. for 3M Corporation, which was completed on August 20, 2003, and adhered to Good Laboratory Practice standards with some exceptions noted regarding analytical reports.
|
2001 |
AR226-1753
|
4a4XBYZLVvpEOV2p3n6G8RaoR |
196 |
|
DuPont's January 25, 2001 letter to the EPA reports the results of blood serum tests for workers potentially exposed to Ammonium Perfluorooctanoate (APFO), revealing a maximum concentration of 9.0 ppm and a mean concentration of 1.53 ppm, with an investigation ongoing into elevated results from a specific job group.
|
2001 |
AR226-1556
|
JNVVQLE2pdOJ0ykwDBmK9Ojq2 |
14 |
|
The document is a letter from the EPA to DuPont Haskell Laboratory requesting clarification on why the results of human blood serum tests for ammonium perfluorooctanoate (PFOA) were submitted as voluntary rather than under TSCA Section 8(e), given potential human health hazard concerns.
|
2001 |
AR226-1557
|
YrdrQQ07kz5O73KZjMOoOOaJN |
1 |
|
The document is a letter from DuPont Haskell Laboratory responding to an EPA request for exposure and use information regarding PFOA, stating that no adverse health effects have been found among exposed employees, and referencing similar findings from studies by 3M Company.
|
2001 |
AR226-1558
|
LgRwY35w4aD9xmmOprkZX2jmd |
2 |
|
The document is a correspondence from the EPA requesting DuPont Haskell Laboratory to provide the complete data set of blood concentrations related to Ammonium Perfluorooctanoate (AFPO) as summarized in their report, following a previous inquiry.
|
2001 |
AR226-1559
|
OJJ873Ewaw8epELn35myXR9mw |
1 |
|
This document from DuPont Haskell Laboratory provides a corrected dataset of blood concentrations of Ammonium Perfluorooctanoate (APFO) in employees potentially exposed to the substance, addressing errors found in a previous report and including data from 1984 to 1995.
|
2001 |
AR226-1560
|
xdeEwMmr4NrY8N8RRxDqnX7zE |
4 |
|
The document reviews pancreatic lesions from the DuPont APFO study, confirming the carcinogenic effects of APFO while noting discrepancies in hyperplasia diagnoses compared to a previous 3M study, ultimately concluding that the findings of the DuPont study remain valid.
|
2001 |
AR226-3630
|
wDdQYbQVBDGoYOKBMyZV1zydd |
5 |
|
The document evaluates the validation reports for the bioanalytical method of detecting PFOS and related analytes in human serum or plasma, sponsored by 3M Environmental Laboratories, focusing on various aspects of method accuracy and stability.
|
2001 |
AR226-3630
|
LJb30d3JZ9v4EZD15Vvy2EnOd |
26 |
|
The document reports on an acute inhalation toxicity study of perfluoroctanesulfonyl fluoride (POSF) conducted by 3M, which found that rats exposed to 1000 ppm of POSF for 4 hours showed no significant adverse effects and had measurable levels of perfluorooctane sulfonate (PFOS) in urine and serum.
|
2001 |
AR226-1781
|
O3n5RM9zqLQZpDJOOgoJzy651 |
18 |
|
This document details the analytical method validation for the determination of perfluorooctanesulfonate (PFOS) in artificial soil, conducted by Wildlife International, Ltd. for 3M Corporation, and completed in compliance with Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
RJyjMZ6y8vg04e7V9eVwD0xbX |
46 |
|
This final report details a toxicity test conducted by Wildlife International, Ltd. for 3M Corporation to assess the effects of PFOS on the seedling emergence of seven plant species, completed in compliance with Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
jgKKNKr6zKKd86yjnDwEm4Nxk |
136 |
|
This document details the analytical method validation for determining perfluorooctanesulfonate (PFOS) in plant tissues, conducted by Wildlife International, Ltd. for 3M Corporation, and completed in compliance with Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
mBgMn324q9kw5p19ZxbJ6adGB |
51 |
|
A monitoring study conducted by Entrix, Inc. for 3M assessed the concentrations of selected fluorochemicals, including PFOS and PFOA, in surface water, sediments, clams, and fish near the 3M facility in Decatur, Alabama, revealing significant PFOS levels at the facility's outfall but no statistically significant changes in water quality downstream.
|
2001 |
AR226-1781
|
0LknVb1ddg5oakZENdXqndGvR |
40 |
|
The document is a final summary report of an extended recovery study on Perfluorooctane Sulfonic Acid Potassium Salt (PFOS) conducted in Cynomolgus monkeys, sponsored by 3M and compliant with EPA Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
zQxEMJjv9099ekoo61YJyZBo7 |
23 |
|
This document is a final report on an acute toxicity study of PFOS conducted with earthworms in an artificial soil substrate, submitted to 3M by Wildlife International, Ltd., and compliant with Good Laboratory Practice standards.
|
2001 |
AR226-1781
|
B5kLOJX7wkZ8324E0d00E5Q6o |
52 |
|
This document details a bioconcentration study of perfluorooctanesulfonate (PFOS) conducted using bluegill fish, produced by 3M, which assessed the substance's uptake and depuration under specific test conditions, revealing a purity of 86.9% and various exposure concentrations.
|
2001 |
AR226-1781
|
RpEb8wQwdv91X6ppQXpwZD74a |
5 |
|
The document details a revised soil adsorption study for Perfluorooctanesulfonate (PFOS), including its purity, testing methods based on OECD guidelines, and soil characteristics from various sources in Minnesota and North Dakota.
|
2001 |
AR226-1781
|
ppRe4pBQ8p6kQ7gBDv28LrDJX |
4 |
|
The document is a peer review of DuPont's use and exposure to perfluorooctanoic acid (PFOA) in their fluoropolymer manufacturing processes, focusing on mass balance assessments and emissions related to their production sites worldwide.
|
2001 |
AR226-1667
|
wqEgja1yyBmMO5BpDoKy3NBmo |
25 |
|
The document discusses the results of whole-body exposures of rats to PTFE fumes, indicating that while most rats showed signs of high toxicity, one was a non-responder and another had a low response, with suggestions for improving exposure methodologies for future studies.
|
2001 |
AR226-1668
|
bX7XBE0g9BrJq3Qyy4rxV05y |
3 |
|
The document is a final report from 3M Company detailing a cross-sectional analysis of serum levels of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) among employees participating in the 2000 medical surveillance program at their Antwerp and Decatur fluorochemical manufacturing plants, highlighting the demographics and participation rates of the employees involved.
|
2001 |
AR226-1781
|
0QeRDJGEBEXEny7qb2obM91R |
122 |
|
The document is a final report from 3M Company detailing a longitudinal analysis of serum levels of Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) in relation to lipid and hepatic clinical chemistry test results among male employees participating in the company's fluorochemical medical surveillance program conducted in 1994/95, 1997, and
|
2001 |
AR226-1781
|
pBdZ5q0GawkVoQoYJXLwOJNwa |
63 |
|
The document reports on an acute inhalation toxicokinetic study of perfluoroctanesulfonyl fluoride (POSF) conducted by 3M, which found that a small percentage of inhaled POSF was converted to perfluorooctanesulfonate (PFOS) in the serum of rats, with no significant adverse effects observed.
|
2001 |
AR226-1781
|
ZBje3Zm2ZRG7z1ENyk7G5V6q8 |
18 |
|
The document details a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on mallards, revealing overt signs of toxicity at higher concentrations, leading to the termination of the 150 ppm and 50 ppm treatment groups due to health concerns.
|
2001 |
AR226-1781
|
9J5p2KbbkbJQyEerZvmepBXpV |
11 |
|
The document reports on a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services, focusing on the extraction of potassium perfluorooctanesulfonate (PFOS) from egg components using HPLC-Electrospray/Mass Spectrometry, and confirms compliance with Good Laboratory Practice standards with noted exceptions.
|
2001 |
AR226-1781
|
03pvN9dyB7X4qdjMyKjqXVrO |
102 |
|
The document is a final report on a reproduction study conducted by Wildlife International, Ltd. for 3M Corporation, assessing the effects of PFOS on mallards, completed on August 21, 2003, and compliant with Good Laboratory Practice standards.
|
2001 |
AR226-1781
|
kJdM4m8nMX89djLxjareRyNy |
203 |
|
The document discusses concerns raised by an engineer regarding the poor recovery rate (25%) of the analytical technique used to measure surfactants, including PFOA, at Parkersburg, indicating that previously reported results may be significantly underestimated and could exceed the safe drinking water level of 1 ppb.
|
2001 |
AR226-1677
|
MGOboEMGGGrEK6NqB84Vr7967 |
1 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from quail serum and liver using HPLC-Electrospray/Mass Spectrometry, ensuring compliance with EPA Good Laboratory Practice Standards.
|
2001 |
AR226-1819
|
bBmmyK9RrLr0dGVXoRLZDjMyO |
102 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from egg components for analysis using HPLC-Electrospray/Mass Spectrometry, noting compliance with EPA Good Laboratory Practice Standards despite some exceptions.
|
2001 |
AR226-1820
|
bBGjz4NEXZqNRpJZ896pO6a7Z |
101 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from mallard serum and liver using HPLC-Electrospray/Mass Spectrometry, ensuring compliance with Good Laboratory Practice standards.
|
2001 |
AR226-1823
|
qarw7Y3BOJdnM1VrMLJzN4N8n |
104 |
|
The document is a laboratory report from 3M Environmental Technology & Safety Services detailing a PFOS dietary LC50 study in northern bobwhite birds, which found that while PFOS levels in liver tissues were consistent across dose groups, sera levels exhibited significant variability among individual animals.
|
2001 |
AR226-1826
|
jmze3oRJ3zY4jkv1mYG8q37V9 |
16 |
|
The document summarizes a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on northern bobwhite quail, detailing the experimental design, treatment concentrations, and observations of toxicity, which led to the termination of higher dose treatments due to adverse effects.
|
2001 |
AR226-1830
|
3oapYB816BYL6wNgEox6BeKa |
11 |
|
The document is a final report on a reproduction study of PFOS conducted on the Northern Bobwhite, sponsored by 3M Corporation and compliant with Good Laboratory Practice Standards, detailing the study's initiation and completion dates, as well as the protocols followed.
|
2001 |
AR226-1831
|
6RkMD8yBmkqomM7nnZXrzQdpg |
42 |
|
The document summarizes a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on mallards, detailing the experimental design, treatment levels, and observations of toxicity, which led to the termination of higher concentration groups due to adverse effects.
|
2001 |
AR226-1835
|
rpdLKVvO5Jneq0zrpRob3EyRE |
11 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of Potassium Perfluorooctanesulfonate from mallard serum and liver using HPLC-Electrospray/Mass Spectrometry, ensuring compliance with US EPA TSCA Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
aJnYg6ER0oQ7wYrpXN1p6Qpze |
104 |
|
The document is a final report on a reproduction study of PFOS conducted on mallards, initiated by 3M Corporation and completed by Wildlife International, Ltd., which adhered to Good Laboratory Practice standards but noted exceptions regarding the reporting of blood and tissue analyses.
|
2001 |
AR226-1836
|
YD1ox4wwvdxKKGdj1dERkyyDn |
58 |
|
This laboratory report details a PFOS dietary LC50 study conducted by 3M Environmental Technology & Safety Services on northern bobwhite birds, revealing significant variability in PFOS levels in sera among individual animals while liver levels showed more consistency, with both tissue types generally increasing with dose level.
|
2001 |
AR226-1781
|
pm37MYkLMr4qgyR3oydX19Nv6 |
16 |
|
The document presents a toxicological summary of a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on Northern bobwhite quail, detailing the experimental design, treatment levels, and observations of toxicity, particularly noting that high doses (150 ppm and 50 ppm) resulted in overt signs of toxicity and were terminated early.
|
2001 |
AR226-1781
|
Ra2jeB0B2zmoBg88q4LDMbw5k |
11 |
|
The document is a final report on a reproduction study of PFOS (perfluorooctanesulfonic acid) conducted on the Northern Bobwhite, sponsored by 3M Corporation and compliant with Good Laboratory Practice Standards, detailing the study's initiation and completion dates along with the protocols used.
|
2001 |
AR226-1781
|
n6958xeGj4v8ym7xae1Nwd21 |
196 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from quail serum and liver using HPLC-Electrospray/Mass Spectrometry, ensuring compliance with Good Laboratory Practice standards.
|
2001 |
AR226-1843
|
2qy8GrodL0q0y45GV9J0b1qJ5 |
102 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of potassium perfluorooctanesulfonate (PFOS) from quail serum and liver using HPLC-Electrospray/Mass Spectrometry, which was performed in compliance with US EPA TSCA Good Laboratory Practice Standards.
|
2001 |
AR226-1781
|
MRQnN35YNLMEjxX8zpXgRye7 |
102 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of Potassium Perfluorooctanesulfonate from egg components using HPLC-Electrospray/Mass Spectrometry, which was performed in compliance with Good Laboratory Practice standards, despite some exceptions noted.
|
2001 |
AR226-1844
|
jgVGZVgbJGNyX4LdERmJj07yR |
102 |
|
This laboratory report from 3M Environmental Technology & Safety Services details a PFOS dietary LC50 study in northern bobwhite, revealing significant variability in PFOS levels in sera among individual animals while liver PFOS levels were more consistent and generally increased with dose level.
|
2001 |
AR226-1850
|
5LwBppy82aJnN9d6JX9z89w1R |
16 |
|
The document details a study conducted by Centre Analytical Laboratories, Inc. for 3M Environmental Technology and Safety Services on the extraction of Potassium Perfluorooctanesulfonate (PFOS) from Mallard serum and liver using HPLC-Electrospray/Mass Spectrometry, ensuring compliance with US EPA Good Laboratory Practice Standards.
|
2001 |
AR226-1847
|
RpnrDJD2DoX0M9O2eLQVa6RyV |
104 |
|
The document details a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on northern bobwhite quail, revealing toxicity at higher concentrations leading to the termination of the 150 ppm and 50 ppm treatment groups due to overt signs of toxicity.
|
2001 |
AR226-1854
|
Ozj4XXYwak04XvKqmqzZyvd31 |
11 |
|
The document summarizes a dietary chronic definitive reproductive study on perfluorooctanesulfonate (PFOS) conducted on mallards, detailing the experimental design, treatment levels, and observations of toxicity, particularly noting that high concentrations (150 ppm) led to early termination of the treatment group due to overt signs of toxicity.
|
2001 |
AR226-1859
|
3QYB0agnoY7E9Gz5926Mp3Y3 |
11 |
|
The document is a final report on a reproduction study of PFOS conducted on the Northern Bobwhite by Wildlife International, Ltd. for 3M Corporation, which was completed on August 20, 2003, and adhered to Good Laboratory Practice standards with some exceptions noted.
|
2001 |
AR226-1855
|
Gzjq619dyXoNLy2OGxqjN3rdY |
196 |
|
The document is a final report on a reproduction study conducted by Wildlife International, Ltd. for 3M Corporation, assessing the effects of PFOS on mallards, completed in compliance with Good Laboratory Practice standards.
|
2001 |
AR226-1860
|
EwvgQjbyk78G9Vbz1LjMYaoV |
202 |
|
The document discusses a slide review of pancreas lesions related to the DuPont study on APFO (perfluorooctanoic acid), conducted by E.E. McConnell and J.R. Foster in November 2001.
|
2001 |
AR226-3630
|
3QqR4OpJbbDa7RDQBmKGrYxza |
1 |
|
The document discusses the evaluation of method validation reports for PFOS and related analytes in human serum or plasma, submitted by 3M for compliance with FDA requirements.
|
2001 |
AR226-3630
|
4QQ2Kd9Lq50MQKVxwg3dxq61x |
1 |
|
Empty document.
|
2001 |
AR226-3630
|
rxjd8z5n54vBJdoDZwo7OJvkJ |
1 |
|
The document is a report evaluating the validation of bioanalytical methods for measuring PFOS and related analytes in human serum or plasma, sponsored by 3M Environmental Laboratories, and authored by Nancy Benson and Philippe Ourisson from Quality Associates, Inc.
|
2001 |
AR226-1907
|
NNNoOE435jXq1Jmpzr3Z2kBkp |
26 |
|
The document reviews pancreatic lesions from the DuPont APFO study, confirming the carcinogenic effects of APFO while noting discrepancies in hyperplasia reporting compared to the 3M study, with a final confirmation pending further slide reviews.
|
2001 |
AR226-1919
|
ZmOOQa8QaV7a4ByzgLeQ5xE0 |
5 |
|
The document discusses a significant increase in C-8 (likely PFOA) test results from area and personal samples in a fine powder area in 1985, with multiple samples exceeding the established acceptable exposure limit, prompting a meeting to address potential health hazards and necessary actions.
|
2001 |
AR226-2001
|
EvNd0JOVQnXmoQ27LOgxkzpON |
1 |
|
The correspondence discusses concerns regarding elevated levels of C-8 (perfluorooctanoic acid, PFOA) detected in the recovery building at DuPont, attributing the source to inadequate venting from fine powder scrubbers rather than liquid solutions, and suggests that the situation may improve with the installation of exhaust filters.
|
2001 |
AR226-2047
|
6RdvmkxvBGp0RbV7dxJyJ3xQ3 |
2 |
|
The document discusses concerns regarding high levels of C-8 (perfluorooctanoic acid, PFOA) measured in the DuPont B-124 building, attributing the presence to dried powder residue rather than vapor pressure, and suggests a thorough wash down of equipment to minimize exposure risks.
|
2001 |
AR226-2048
|
nBpXVyrEKkMN0xz89ebbJK86 |
2 |
|
The document presents industrial hygiene test results for perfluorinated compounds (C-8/FC-143) from various locations within a Teflon production facility, indicating concentrations that exceed action levels during the sample date range of January to December 1989.
|
2001 |
AR226-2099
|
5DoQNxwXNwEvDj9kr3Rp8me0V |
7 |
|
The document presents test results from 1991 for perfluorinated compounds (C-8/FC-143) at Pern Chemical, indicating various concentrations exceeding action levels in multiple locations within the facility.
|
2001 |
AR226-2100
|
9dd2bdML8QNyNyw4vbM1jOo6 |
9 |
|
The document presents industrial hygiene test results for C-8/FC-143 (a perfluorinated compound) from various locations within a Teflon production facility, indicating concentration levels and their percentages relative to action levels over multiple sample dates in 1992.
|
2001 |
AR226-2101
|
jOEN1Vy9vkgExJp3GxLELm0O |
3 |
|
The document presents industrial hygiene test results for perfluorinated compound C-8/FC-143, indicating various concentrations detected in samples taken from Teflon production locations between January and December 1993, with some samples exceeding action levels.
|
2001 |
AR226-2102
|
ym9Nope82OZZk3x8odz7b67N2 |
5 |
|
The document presents industrial hygiene test results for perfluorinated compound C-8/FC-143 (PFOA) exposure levels among employees in various Teflon production areas during 1994, indicating concentrations ranging from 300 to 420 parts per million.
|
2001 |
AR226-2103
|
zGL7mVmBXkDxXNDvkbVbRqZa |
5 |
|
The document presents test results for PFOA (C-8) concentrations in various locations of a Teflon production facility, indicating that all samples collected in 1977 showed concentrations below 0.1 PPM.
|
2001 |
AR226-2104
|
baMNg09va6G67GZ25JZgOkXg1 |
1 |
|
The document presents industrial hygiene test results for PFOA concentrations in various locations associated with the production of Teflon, indicating multiple sample dates and concentration levels, with some samples showing very low PFOA levels.
|
2001 |
AR226-2106
|
yrG7No0o59xxO8eagyNnMjeJD |
5 |
|
The document provides a summary of industrial hygiene sampling results for perfluorinated compounds (C-8) related to Teflon production, indicating various concentrations measured in parts per million (PPM) across multiple dates and locations in 1980.
|
2001 |
AR226-2107
|
kv7M8NXj1o6DEEjmq2dJ03xb |
9 |
|
This document contains industrial hygiene test results for various samples collected from different locations within a facility, detailing concentrations of a chemical identified as C-8, with measurements primarily below 0.0015 PPM.
|
2001 |
AR226-2109
|
2J597Zj05N5NkVKbxR3Zn9qr |
23 |
|
The document details industrial hygiene sampling results for perfluorinated compounds (C-8/FC-143) conducted by Pera Chemical in 1981, indicating various concentration levels that exceed action levels.
|
2001 |
AR226-2108
|
jyO4Y8jBKX8XgQvdLRoE7qdyQ |
31 |
|
The document presents industrial hygiene test results for perfluorinated compounds (C-8/FC-143) from various locations in a facility during 1987, indicating concentrations ranging from 300 z to 510 z across multiple sampling dates.
|
2001 |
AR226-2114
|
0qeYrLw8kRQBNkJr5M1L2KBpJ |
10 |
|
The document provides industrial hygiene sampling data for perfluorinated compounds (C-S/FC-143 and C-8/FC-143) related to Teflon production, detailing sample dates, concentrations, and locations within the facility, indicating high levels of exposure.
|
2001 |
AR226-2113
|
gDnvqD8YRKrm11EL9xQkMo3Na |
11 |
|
The document provides a summary of industrial hygiene sampling results for perfluorinated compounds (C-8/FC-143) from various locations in a Teflon production facility during 1984, detailing concentration levels and sample dates.
|
2001 |
AR226-2112
|
06zBbX8GbDvQ5aQ2RJjpVX52d |
23 |
|
The document presents industrial hygiene test results for perfluorinated compounds (C-8/FC-143) from various sampling locations at Pere Chemical during 1988, indicating concentrations ranging from <0.03 MPB to 5.4% across multiple samples.
|
2001 |
AR226-2115
|
O3x1k5MzJQQbEbEpV504Jmw8j |
12 |
|
The document presents industrial hygiene sampling results for perfluorinated compounds, specifically C-8 and C-6, from various employees at Petrs Chemical, indicating concentration levels and compliance with action levels over multiple sampling dates in 2000.
|
2001 |
AR226-2116
|
Dv0Rrp6vMozE6B20r7wLV7VdB |
8 |
|
The document presents industrial hygiene test results from Pere Chemical for various samples taken between January and December 1983, indicating concentrations of C-8/FC-143, a perfluorinated compound, with varying levels detected across different sampling dates.
|
2001 |
AR226-2111
|
5bxdQMnB7DD6BY6DowNVv0mZ0 |
43 |
|
The document presents test results for C-8 (likely referring to perfluorooctanoic acid, PFOA) concentrations in the workplace, showing various measurements in parts per million (PPM) from samples taken between 1970 and 1981, with all results indicating concentrations at or near zero.
|
2001 |
AR226-2118
|
kLmYDKzyp45prDGkdYbNmV7J |
9 |
|
The document presents industrial hygiene test results for perfluorinated compounds (C-8/FC-143) from various samples collected at a chemical facility, indicating concentration levels and compliance with action levels.
|
2001 |
AR226-2110
|
N27x4zLyLQjG0yKDegJbx9qLV |
54 |
|
The document presents test results from December 11-13, 1979, indicating the concentration of C-8 (likely referring to PFOA) in two samples from TEFLON production, with concentrations below the action level of 0.0001 PPM.
|
2001 |
AR226-2120
|
VJv5Qn6DbkN435VBrLJMKOGop |
2 |
|
The document presents test results for C-8/FC-143, a perfluorinated compound, indicating various concentration levels ranging from 0.03% to over 6.0% across multiple samples collected between 1981 and 1992 in an industrial setting.
|
2001 |
AR226-2122
|
RJq6b7onEp79ZKeKvNDL3eq8 |
4 |